Mesoporous polydopamine-based nanodrug delivery systems for tumor immunotherapy.

Wen Y, Li R, Ke J, Wang M, Wu S, Feng B, Xie L, Jing P, Tao C, Huang Y, Zhou M

Open source

DOI
10.1039/d6nh00175k
Published
2026 Sep 15
Container
Nanoscale horizons
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1039/d6nh00175k,
  title = {Mesoporous polydopamine-based nanodrug delivery systems for tumor immunotherapy.},
  author = {Wen Y and Li R and Ke J and Wang M and Wu S and Feng B and Xie L and Jing P and Tao C and Huang Y and Zhou M},
  year = {2026},
  journal = {Nanoscale horizons},
  doi = {10.1039/d6nh00175k},
  url = {https://doi.org/10.1039/d6nh00175k}
}

RIS

TY  - JOUR
TI  - Mesoporous polydopamine-based nanodrug delivery systems for tumor immunotherapy.
AU  - Wen Y
AU  - Li R
AU  - Ke J
AU  - Wang M
AU  - Wu S
AU  - Feng B
AU  - Xie L
AU  - Jing P
AU  - Tao C
AU  - Huang Y
AU  - Zhou M
PY  - 2026
JO  - Nanoscale horizons
DO  - 10.1039/d6nh00175k
UR  - https://doi.org/10.1039/d6nh00175k
ER  - 

APA

Y, W., R, L., J, K., M, W., S, W., B, F., L, X., P, J., C, T., Y, H., & M, Z. (2026). Mesoporous polydopamine-based nanodrug delivery systems for tumor immunotherapy.. Nanoscale horizons. https://doi.org/10.1039/d6nh00175k

Source records